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Methods for human skin gene therapy requires efficient and stable introduction of genes into skin cells. Transient
cutaneous gene therapy is an attractive approach in the treatment of skin diseases. The ‘Achilles heel’ of adenoviral
gene therapy is its immunogenicity and many aspects of adenovirus induced cutaneous immune reaction still
remain unanswered, particularly the role of keratinocytes. Therefore, human keratinocytes were transfected with
adenoviral DNA and cytokine expression was analyzed. Moreover, adenoviral transduction of full-skin was
performed ex vivo and in vivo. We observed cytokine induction after cytoplasmatic internalization of adenoviral DNA
into epidermal cells. Inhibition of AIM2, NALP3, DAI or mda5 downregulated the cytokine response. Transduction of
immunocompetent mice led to a detectable transgene expression for 12 days. Re-application of the vector led to a
decrease in intensity and duration of transgene expression limited to 4 days and an increased cytokine expression.
In contrast, immunodeficient mice showed a reduced expression of cytokines after DNA internalization. AIM2,
NALP3, DAI and mda5 are essential in the induction of an innate immune response towards adenoviral DNA. This
immune reaction leads to a decrease in transduction efficiency of the vector after re-application and modulation of
these receptor systems stabilizes transgene expression.
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The skin is the biggest and most important organ in
protecting the body from a hostile environment. The
epidermis, its outside layer, is mainly composed of
keratinocytes, which guard the body against physical,
chemical, or biological damage by establishing a protect-
ive layer (Bouwstra et al. 2003). Its accessibility makes
the skin an easily approachable target for the treatment
of both local and systemic diseases via gene therapy
(Kim et al. 2000). Gene therapy is a promising tool for
the treatment of a wide variety of inherited as well as ac-
quired disease including genetically inherited skin disor-
ders, tumors, metabolic disorders and infectious diseases
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in any medium, provided the original work is pproperties make the skin a very interesting organ for
in vivo and ex vivo gene therapy approaches. Gene deliv-
ery can be easily controlled and the skin surgically ex-
cised if any side effects occur (Christensen et al. 2001).
Keratinocytes are responsible for establishing a physical
barrier and guaranteeing the structural integrity of the
epidermis (Bouwstra et al. 2003). As the epidermis is
known to produce a variety of cytokines and growth fac-
tors, keratinocytes may also be engineered as bioreactors
to secrete gene products, which have local or systemic
effects (Tomic-Canic et al. 1998). Its accessibility sug-
gests that different methods for gene delivery can be
pursued, depending on the desired application. The ap-
proach used to deliver DNA into the skin will have an
influence not only on the efficiency of DNA delivery,
but also on the level and duration of transgene expres-
sion (Worgall et al. 1997). For transient transduction of
target cells, adenoviral vector systems possess the
highest efficacy and have been used in 23.3% of thean Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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cades (JGT 2012).
Adenoviridae are non-enveloped, double stranded (ds),
linear desoxyribonucleic acid (DNA) viruses with a gen-
ome of 35–40 kb and a particle size of 70–100 nm (Rux
& Burnett 2004). The adenoviral genome is well charac-
terized and comparatively easy to manipulate. Most ade-
noviruses cause mild diseases in immunocompetent
human adults and by deletion of crucial regions of the
viral genome the vectors can be rendered replication de-
fective, which increases their predictability and reduces
unwanted side effects. Moreover, deleted regions of the
viral genome can easily be replaced by foreign genomic
material encoding the therapeutically active metabolite
(Tatsis & Ertl 2004). The process of adenoviral entry into
the host is extremely efficient and has been intensively
studied (Douglas 2007). Adenoviruses exhibit a wide
host range in vitro and in vivo; this range was also seen
in nondividing cells (Zhang 1999). In addition, the well-
defined and easily manipulated viral genome favors the
development of adenoviral vectors for gene therapy ap-
plications. A major disadvantage of adenoviral vectors is
that viral DNA can effectively elicit the innate and adap-
tive immune response immediately after infection, lead-
ing to the secretion of pro-inflammatory cytokines in
mice, primates and humans (Raper et al. 2003; Schnell
et al. 2001; Zhang et al. 2001). Activation of innate im-
munity is associated with a reduction in efficacy of gene
transfer (Worgall et al. 1997) but also in profound dam-
age to healthy tissue and significant morbidity in trans-
duced hosts (Raper et al. 2003; Schnell et al. 2001).
Several studies focused on the immune reaction elicited
through cytoplasmatic localized adenoviral DNA. This
led to the development of newer generations of adeno-
viral vector systems that were depleted of a number of
viral genes in order to reduce the immune reaction.
Helper-dependent adenoviral vectors lack almost all viral
coding sequences and lead to diminished adaptive im-
mune responses and improved duration of gene transfer
(Muruve 2004). However, acute toxicity and reduced
vector persistence provoked by the innate immune re-
sponse remain the most significant barriers to an effect-
ive clinical application of this promising technology
(Brunetti-Pierri et al. 2004).
Several studies on adenoviral DNA induced innate im-
mune reaction have focused on antigen presenting cells
(APCs) such as dendritic cells (DCs) or macrophages
(MΦ) (Nociari et al. 2007; Zhu et al. 2007) and RNA
virus-induced immune reactions of APC (Lopez et al.
2006). In addition to adenoviral DNA, activation of in-
nate immunity has also been described for vertebrate
and mammalian DNA, and synthetic oligonucleotides
(Nociari et al. 2007; Zhu et al. 2007). Moreover, a se-
quence independent mechanism for cytoplasmatic DNArecognition and immune activation has been specified
(Suzuki et al. 1999). The detection of microbial compo-
nents by pattern recognition receptors (PRRs) is one
of the earliest defense mechanisms to trigger innate
immune responses against infections (Janeway &
Medzhitov 2002). Of the many classes of molecules
detected by cells as pathogen associated molecular pat-
terns (PAMPs), nucleic acids are potent and broadly rec-
ognized (Isaacs et al. 1963). In order to sense nucleic
acids the immune system employs several classes of re-
ceptors. The family of Toll-like receptors (TLRs) in this
context is the best described group of PRRs. TLRs can
recognize endosomal doublestranded (ds)RNA (TLR-3)
(Alexopoulou et al. 2001), singlestranded (ss)RNA (TLR-
7/-8) (Diebold et al. 2004), or hypomethylated DNA
(TLR-9) (Hemmi et al. 2000). Activation of nucleic acid
sensing TLRs occurs within endosomal compartments
(TLR-3, -7, -8 and −9) and requires either a myeloid dif-
ferentiation primary response gene 88 (MyD88) or TIR-
domain-containing adapter-inducing interferon-β (TRIF)
adapter molecules. These proteins facilitate activation of
downstream signaling cascades, which lead to the activa-
tion of inflammatory transcription factors, including nu-
clear factor-kappa B (NFκB), activator protein 1 (AP-1)
and interferon regulatory factors (IRF) 3 and 7. An acti-
vation of downstream cascades leads to a release of in-
flammatory cytokines which play an inportant role in
direct or indirect viral clearing mechanisms. A direct
mechanism is associated with a recruitment of inflam-
matory cells, activation of adaptive immune system and
complement system whereas an indirect mechanism is
represented by a further induction of inflammatory sig-
nalling, for example an activation of JAK/STAT-signal-
ling. The JAK/STAT-signal cascade is activated mainly
through cytokine receptors on the cell surface and
thereby plays during an infection in the communication
between cells play a central role. An activation of this
signaling cascade leads to further induction of cytokine
synthesis in the cell (Kanehisa 2012).
Since the discovery of TLR-9, there has been a grow-
ing body of evidence that DNA derived from microbial
and host cells can be recognized via a TLR-9-independ-
ent mechanism. DNA recognition in these pathways is
sequence independent and occurs in the cytoplasm of
the cells (Suzuki et al. 1999). Different ligands, such as
adenoviral, mammalian and vertebrate DNA as well as
dsDNA have been characterized for TLR-independent
recognition in APCs (Martin & Elkon 2006; Nociari
et al. 2007; Zhu et al. 2007). In addition to TLRs, the
RIG-like receptor (RLR) mediated signal transduction
has also been discussed for DNA-recognition wherein a
corresponding DNA-sensing receptor in this signaling
cascade has not been identified yet (Nociari et al. 2007).
RLR-dependent signaling is induced by recognition of
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inducible gene I (RIG-I) and melanoma differentiation
associated gene 5 (mda5)) and requires an adapter mol-
ecule IPS-1 (mitochondrial antiviral signaling protein 1).
Downstream signaling results in an NFκB-, AP-1- and
IRF-3/7-dependent induction of cytokine expression
(Yoneyama & Fujita 2007). In 2009, a DNA sensor and
activator of innate immune responses has been identified
and termed DNA-dependent activator of IFN-regulatory
factors (DAI and also known as DLM-1 and ZBP1)
(Takaoka et al. 2007). The activation of DAI leads to
a RIP1/3-dependent activation of NFκB. Hence, an acti-
vation of IRF-3 and IRF-7 has also been reported
(Kanehisa 2012). Subsequent studies have shown the
presence of an additional mechanism(s) for DNA-
sensing and activation of the innate immune system.
NACHT-leucine-rich repeat-PYD containing protein 3
(NALP3) also known as cryopyrin, and its adaptor pro-
tein apoptosis-associated speck-like protein containing a
CARD (ASC), regulate secretion of interleukin (IL)-1β in
response to an adenovirus infection. Inflammasome acti-
vation also occurs upon cytosolic exposure of DNA,
though in different other reports DNA-sensing was
shown to be dependent on ASC and not NALP3
(Muruve et al. 2008). In particular a group of proteins
of the HIN-200 (hematopoietic interferon-inducible
nuclear proteins with a 200-amino-acid repeat) protein
family, which exhibit a DNA-binding domain along with a
CARD-domain, became more and more important in the
last years. For this protein family, an induction of innate
immunity dependent of AIM2 (absent in melanoma 2)
and IFI16 (gamma-interferon inducible protein 16)
via ASC has been described (Roberts et al. 2009;
Unterholzner et al. 2010).
However, data on the role of epithelial cells in innate
immunity, particularly in response to DNA internaliza-
tion and DNA virus infection is limited. Also, there is a
lack of information about constitutive expression of in-
flammatory factors in keratinocytes, as well as data
about the induction of inflammatory factors after adeno-
viral DNA internalization still are missing. On the way
to improve safety, efficacy and duration of cutaneous
adenoviral gene therapy it is necessary to get a basic
knowledge on the reaction of epidermal cells in response
to adenoviral gene delivery. This study was performed in
order to depict the important role of human epidermal
cells in innate immunity towards adenoviral vector sys-
tems. This will help to fine tune various therapeutic
intervention strategies. Therefore, this study observed the
mechanisms of innate immune reaction of cultured
keratinocytes in vitro, the immune response to adenoviral
gene delivery into human skin samples ex vivo by using a
human full skin culture system (Steinstraesser et al. 2009)
and in vivo, using a murine transduction model.Materials and methods
Keratinocyte cell culture
Fresh human skin was obtained after abdominoplasty
surgery (informed consent was given by the patient) and
washed in PBS (PAA Laboratories, Coelbe, Germany).
The skin was placed in a sterile petri dish and the hypo-
dermis was excised. The skin was disinfected with
Lavasept (Braun AG, Melsungen, Germany) for 5 min
and washed with PBS, the tissue was sliced into pieces
of 1 cm2. Skin pieces were transferred into a new petri
dish with the epidermal side up and the skin was com-
pletely immersed with freshly prepared 0.2% dispase-
solution (4.7 U/ml, Gibco, Paisley, United Kingdom
[UK]) and incubated overnight at 4°C. The epidermis
was peeled off and placed in Trypsin/EDTA-solution
(0.05%/0.02%, Gibco, Paisley, UK) and reduced to pieces
as small as possible. The pieces were incubated at 37°C
for 20 min in a gently shaking (180 rpm) waterbath
(GFL Burgwedel, Germany). The cell suspension was
vortexed and the trypsin digestion was stopped by
adding fetal bovine serum (FBS, HyClone, Logan, USA).
The suspension was filtered through a 100 μm cell
strainer (Becton Dickinson Heidelberg, Germany) and
centrifuged at 400 × g, 20°C for 5 min. The cells were
resuspended in a 5 ml keratinocyte medium (containing
3:1 Dulbecco’s Modified Eagle Medium (DMEM,
Gibco, Paisley, UK), Ham’s F12 (Gibco, Paisley, UK),
10% FBS (Hyclone, Logan, USA), 1% Penicillin/
Streptomycin (ICN, Aurora, USA), 4 mM L-Glutamin
(ICN, Aurora, USA), 24.3 μg/ml Adenine (Calbiochem,
Darmstadt, Germany),5 μg/ml Insulin (Sigma, St.
Louis, USA), 0.8 μg/ml Hydrocortisone (Calbiochem,
Darmstadt, Germany), 1.346 ng/ml Triiodothyronine
(Sigma, St. Louis, USA), 1 μM Isoproterenol (Sigma, St.
Louis, USA), 20 ng/ml hEGF (Sigma, St. Louis, USA)
and counted by CASY-1 (Schärfe-System, Reutlingen,
Germany). Cells were seeded at a density of 75,000
cells/cm2 into collagen type I (Becton Dickinson
Falcon, Heidelberg, Germany) precoated culture flasks. All
different cell types including HaCaT (kindly provided by
Prof. Fusenig, University of Heidelberg) cell lines were
cultured at 37°C in humidified atmosphere of 5% CO2.
HaCaT cells were cultured in DMEM containing 10% FBS
(Hyclone, Logan, USA) and 1% Penicillin/Streptomycin.
Medium was changed every second day.
Human full skin culture
Fresh, sterile human skin explants were obtained in the
operating room of the University Hospital Bergmannsheil,
Bochum, Germany from six adult healthy patients (six dif-
ferent donors; age range: 19–43 years) undergoing
abdominoplasty surgery. The study was approved by the
local ethics committee (registration number: 2501; institu-
tional review board of the Faculty of Medicine, Ruhr-
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Skin explants were cultured as described by Steinstraesser
et al. (Steinstraesser et al. 2010). For transduction, 1010 in-
fectious units (IU) Ad-GFP (green fluorescent protein)
in 50 μl PBS were intradermally injected (n = 6 samples
from two different donors per group). 3 to 96 h post
transduction, tissue biopsy specimens were harvested
for total RNA isolation. Transgene expression was lo-
calized via Kodak Imaging Station 4000MM and Kodak
MI software.
Production and purification of recombinant adenovirus
A replication-deficient human ΔE1 adenovirus type 5
(Ad5) with inserted cytomegalovirus (CMV)-promoter
driven green fluorescent protein (GFP), ΔE1-Ad5-CMV-
GFP, was used as described by Steinstraesser et al.
(Steinstraesser et al. 2011).
DNA purification, RNA isolation and Reverse Tran-
scription were performed as described by Steinstraesser
et al. (Steinstraesser et al. 2011).
Transfection
Cells were grown in 6-well plates until 90-100%
confluency. DNA transfection complexes were prepared
according to the manufacturer’s instructions (Roche Mo-
lecular Biochemicals, Mannheim, Germany). Briefly,
ΔE1-Ad5-CMV-GFP DNA was mixed in ratio of 2:5
with the Fugene® HD transfection reagent (Roche Mo-
lecular Biochemicals, Mannheim, Germany) in PCR-
grade water (Roche Molecular Biochemicals, Mannheim,
Germany) for 15 min at room temperature and then
added to cells. If not mentioned otherwise, all transfection
experiments were performed in triplicate for each group.
For siRNA transfection, keratinocytes were sown in a
density of 15.000 cells/cm2 (HaCaT) or 35.000 cells/cm2
(HKC) in 12-well cell culture plates. After 24 hours the
medium was changed and 400 μl serum-reduced medium.
The siRNA transfection complex was generated by com-
bining siRNA (Eurofins MWG Operon, Ebersberg,
Germany) and X-tremeGENE® siRNA Transfection Re-
agent (Roche, Mannheim, Germany) in Opti-MEM (PAA
Laboratories, Coelbe, Germany) according to manufac-
turer’s instructions (ratio of gene X-tremeGENE®: siRNA
= 1: 0.2). Before DNA transfection, the cells were culti-
vated for another 48 hours with siRNA-transfection com-
plexes. Specific siRNA sequences are listed in Table 1.
Protein inhibition
Prior to transfection, cells were pretreated with specific
inhibitors (10 μM each) for NFκB (IκB–α inhibitor
BAY117082 in DMSO), ERK1/2 (PD98059 in DMSO),
p38 MAPK (SB203580 in DMSO), JNK (JNK II–inhibi-
tor SP600125 in DMSO) and JAK-STAT (AG490 inEtOH) according to manufacturers instructions (Sigma,
Steinheim, Germany).
Real-time PCR
Relative Quantification of mRNA was performed in a
two-step real-time RT-PCR procedure using the fluores-
cent dye SYBR Green I (Light Cycler FastStart DNA
Master SYBR Green I, Roche, Mannheim, Germany) and
a Light Cycler 480 (Roche, Mannheim, Germany). The
first step consisted of an RT reaction as described above,
the second step of PCR amplification with specific
primers listed in Table 2. These primer pairs were
validated to generate a single PCR-product. The PCR
reactions were performed with 2 μl of cDNA, 0.5 μM
of sense and antisense primers, 3 mM MgCl2 and
2 μl of FastStart SYBR Green reaction mix in a total
volume of 20 μl. The cycling conditions were as follows:
95°C for 10 min at a ramp speed of 20°C/sec, 40 cycles
(if not differently described) consisting of 94°C for
15 sec at a ramp speed of 20°C/sec, A primer specific
annealing temperature (Table 1) for 10 sec at a ramp speed
of 20°C/sec, 72°C for 10 sec at a ramp speed of 20°C/sec,
followed by a melting point analysis: 95°C for 0 sec at a
ramp speed of 20°C/sec, 65°C for 15 sec at a ramp speed of
20°C/sec, 95°C for 0 sec at a ramp speed of 0.1°C/sec, and
finally a cooling phase: 40°C for 30 sec at a ramp speed of
20°C/sec. mRNA concentrations were corrected to 18S
rRNA in each sample and were normalized to an untreated
control (x-fold expression).
Animal studies
The research protocol described below conformed to all
regulations related to animal use and other German fed-
eral statues. It was performed in compliance with the
‘Guide for the Care and Use of Laboratory Animals’ as-
sociated with the German Animal Welfare Act. The ani-
mals were housed at an ambient temperature of 20 ± 2°C
and on a 12: 12 h light/dark cycle. Both food and water
were available ad libitum. Athymic mice (Foxn1nu) were
obtained from Harlan Winkelmann (Borchen, Germany)
and immunocompetent mice (SKH-1h/r) were obtained
from Charles River (Wilmington, Sulzfeld, Germany). In
Table 2 List of oligonucleotides used for RT-PCR (h: human; m: murine; f: forward primer; r: reverse primer; TG: target
gene; AT: annealing temperature)
Target gene (TG) Sequence [5′-3′] AT[°C]
Interferon α (human) - NM_024013.2 hIFN-α1 f: acccacagcct ggataacag 60
r: ctctcctcctgcatcacaca
Interferon β (human) - NM_002176.2 hIFN-β f: actgcctcaaggacaggatg 60
r: agccaggaggttctcaacaa
Interleukin 1α (human) - NM_000575.3 hIL-1α f: aatgacgccctcaatcaaag 60
r: tgggtatctcagqcatctcc
Interleukin 6 (human) - NM_000600.3 hlL-6 f: caatgaggagacttgcctgg 63
r: gcacagctctggcttgttcc
Interleukin 8 (human) - NM_000584.3 hIL-8 f: tctgcagctctgtgtgaagg 63
r: aatttctgtgttggcgcagt
Tumor necrosis factor α (human) - NM_000594.3 hTNFα f: aacctcctctctgccatcaa 62
r: ggaagacccctcccagatag
18S ribosomal RNA (human) - X03205.1 hl8S f: gaaaatgcgaatggctcattaaa 60
r: cacagttatccaagtaggagagg
Toll-like receptor 3 (human) - NM_003265.2 hTLR-3 f: agccttcaacgactgatgct 60
r: tttccagagccgtgcta.agt
Toll-like receptor 7 (human) - NM_016562.3 hTLR-7 f: ccacaaccaactqaccactg 60
r: ccacca.gacaaaccacacag
Toll-like receptor 8 (human) - NM_138636.4 hTLR-8 f: gtttcctcgtctcgagttgc 60
r: tcaaaggggtttccgtgtag
Toll-like receptor 9 (human) - NM_017442.3 hTLR-9 f: cctattcatggacggca.act 60
r: gagtgacaggtgggtgaggt
Myeloid Differentiation Primary Response Gene 88 (human) - NM 001172567.1 hMyD88 f: tgcagagcaaggaatgtgac 60
r: aggatgctggggaactcttt
Interferon Regulatory Factor 3 (human) - NM 001571.5 hIRF-3 f: qaggtgacagccttctaccg 60
r: tgcctcacgtagctcatcac
Interferon Regulatory Factor 7 (human) - NM 001572.3 hIRF-7 f: taccatctacctgggcttcg 60
r: gctccataaggaagcactcg
Melanoma Differentiation-Associated Gene 5 (human) - NM_020746.4 hMda-5 f: ggggcatggagaataactca 60
r: tgcccatgttgctgttatgt
NACHT, LRR and PYD Domains-Containing Protein 3 (human) - NM 004895.4 hNALP3 f: cttctctgatgaggcccaag 60
r: gcagcaaactggaaaggaag
Retinoic Acid inducible Gene l(human) - NM 014314.3 hRIG-I f: gcaacagtgcagaggtgaaa 60
r: caaaagagcatccagcaaca
Interferon α (murin) - NM_010502.2 mIFN-α f: tcaatgacctgcaagctgtc 62
r: agcaattggcagaggaagac
Interferon β (murin) - NM_010510.1 mIFN-β f: ccctatggagatgacggaga 60
r: ctgtctgctggtggagttca
Interleukin 1α (murin) - NM_010554.4 mIL-1α f: gcaacgggaagattctgaag 62
r: tgacaaacttctgcctgacg
Interleukin 6 (murin) - NM_031168.1 mIL 6 f: ccggagaggagacttcacag 60
r: tccacgatttcccagagaac
Tumor necrosis factor α (murin) - NM_013693.2 mTNFα f: ccgatgggttgtaccttgtc 60
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Table 2 List of oligonucleotides used for RT-PCR (h: human; m: murine; f: forward primer; r: reverse primer; TG: target
gene; AT: annealing temperature) (Continued)
r: cggactccgcaaagtctaag
18S ribosomal RNA (murin) - NR_003278.3 m18S f: cgcggttctattttgttggt 60
r: agtcggcatcgtttatggtc
Green Fluorescent Protein - L29346.1 GFP f: acgtaaacggccacaagttc 60
r: aagtcgtgctgcttcatgtg
DNA- Dependent Activator of Interferon- Regulatory Factors (human) - NM 030776.2 hDAI f: aaag catggacgattta ccg 60
r: atgatgttcccgtgtccaat
Interferon, gamma- inducible Protein 16 (human) - NM 001206567.1 hIFI16 f: gctgaccgaaacatggagat 60
r: cagatctcaactccccggta
Interleukin 1β (human) - NM_000576.2 hIL-1β f: ttcgacacatgggataacga 60
r: tctttcaacacgcaggacag
TIR- Domain-containing Adapter-inducing Interferon-β (human) - AB093555.1 hTRIF f: caggagcctgaggagatgag 60
r: ctgggtagttggtgctggtt
Interferon-beta Promoter Stimulator 1 (human) - AB232371.1 hIPS-1 f: ataagtccgagggcaccttt 60
r: gtgactaccagcacccctgt
Abscent In Melanoma 2(human) - NM_004833.1 hAM2 f: gctgcaccaaaagtctctcc 60
r: tcaaacgtgaagggcttctt
Caspase-l (human) - NM_033292.3 hCASP-1 f: gaaggcatttgtgggaagaa 60
r: ggtgtggaagagcagaaagc
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domized into three groups with n = 3 mice. Each animal
was intradermally transduced with 108 - 1010 IU Ad-
GFP in 50 μl PBS at two discrete areas on the back.
Transgene expression was localized and quantified every
second day via Kodak Imaging Station 4000 MM and
Kodak MI software. 14 and 28 days after the first injec-
tion a second and third virus application was adminis-
tered into the same areas and into a non-treated area.
In the second experiment, SKH-1h/r and Foxn1nu mice
were each divided into six groups with n = 3 mice. Four
distinct areas at the back of each mouse were marked.
On day 0, 1010 IU Ad-GFP in 50 μl PBS or PBS alone
were injected intradermally into two areas per mouse
followed by a second injection of 1010 IU Ad-GFP into
all four areas on day 14. 1, 6, 24, 48, 72 and 120 h after
the second injection, one group was euthanized by in-
traperitoneal injection of 0.5 ml T61 (MSD Animal
Health GmbH, Luzern, Switzerland), the transduced
skin areas were excised and snap frozen in liquid nitro-
gen for RNA isolation.
Statistical analysis
Differences were analyzed for statistical significance with
the student’s t-test. Error bars represent standard errors
of the mean (SEM). RT-PCR analysis was displayed asexpression ratio of treated and untreated (vehicle con-
trol) cells (x-fold expression).
Results
Applicability of HaCaT cells and primary human
keratinocytes (HKC)
Initially baseline expression of potential key molecules of
the innate immune reaction after adenoviral transduc-
tion have been analyzed in primary human keratinocytes
(HKC) and a keratinozyte cell line (HaCaT) via qRT-
PCR (n = 6 samples).
The data analysis showed a clearly detectable expres-
sion of type-I-interferons (IFN-α and-β), interleukins
(IL-1α,-1β and −6), chemokines (IL-8), tumor necrosis
factor (TNFα) and interferon-regulatory factors (IRF-3
and −7) in HaCaT cells and HKC (Figure 1A). Even
members of the Toll-like receptor family (TLR-3, -7, -9,
MyD88 and TRIF), the RIG-like receptors (RIG-I,
mda5, IPS-1 and STING) and NOD-like receptors (NALP3,
AIM2 and caspase-1) and the DNA-binding protein DAI
could be detected in both cell types. Based on these data,
both cell types show an applicability for the following
experiments. HaCaT cells, however, showed a significant
higher mRNA expression in nine out of twenty-two
genes measured. Apart from the basic applicability of
both cell types, these differences in cytokine expression
Figure 1 Cutaneous adenoviral gene delivery. (A) Baseline expression of cytokines and potentially in cytoplasmatic nucleic acid recognition
involved receptors or adapter molecules in HaCaT cells and primary human keratinocytes (HKC). Data was generated via qRT-PCR and is displayed
as mRNA concentration in ng/g 18S rRNA (* = p < 0,05; ** = p < 0,005). (B) Comparative efficiency of adenoviral vectors in HaCaT cells amd HKC.
Quantitative analysis of GFP-positive cells 48 hours after transfection or transduction of HaCaT cells and HKC with 5 μg adenoviral DNA (AdDNA
[5μg]) or 1.1 × 10
9 IU (AdV[0,5μg]) and 1.1 × 10
10 IU (AdV[5μg]) adenoviral vectors (* = p < 0,05; ** = p < 0,005). (C) Comparative GFP expression in
HaCaT cells and HKC. The specific transcript was determined 48 h after transfection with 5 μg/ml medium of isolated adenoviral DNA (AdDNA
[5μg]) and compared to transduction with 1.1 × 10
9 IU (AdV[0,5μg]) and 1.1 × 10
10 IU (AdV[5μg]) of a GFP-encoding adenoviral vector (* = p < 0,05;
** = p < 0,005). (D) Comparative type-I-interferon expression in HaCaT cells and HKC. The specific transcript was determined 6 h after transfection
with 5 μg/ml medium of isolated adenoviral DNA (AdDNA[5μg]) and compared to transduction with 1.1 × 109 IU (AdV[0,5μg]) and 1.1 × 1010 IU
(AdV[5μg]) of a GFP-encoding adenoviral vector (* = p < 0,05; ** = p < 0,005). (E) Comparative cytokine expression after transfection of HaCaT cells
and HKC with 5 μg/ml isolated adenoviral DNA for 15 h (HaCaT) or 6 h (HKC). These time points were determined (maximum expression) by a
time course of cytokine expression in hacats in a previous study by Steinstraesser et al. (Steinstraesser et al. 2011). Study groups included n = 18
(type-I-IFN) or n = 6 (cytokines) samples. Data was normalized to a vehicle control (* = p < 0,05; ** = p < 0,005).
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data generated in the following experiments.
Comparative analysis of transfection and transduction
efficacy in keratinocytes
In order to determine the transduction efficacy of the used
vector, keratinocytes were transfected/transduced with 5
μg of isolated DNA and an equivalent dose of adenoviral
vectors (1.1 × 1010 infection units (IU)). A quantitative
analysis of GFP-positive cells (Figure 1B) showed a trans-
fection efficiency of 15% in HaCaT cells and 9% for HKC.
Interestingly, transduction of keratinocytes with 1.1 × 109
IU Ad-GFP (= 0.5 μg DNA) resulted in a significantly lar-
ger number of GFP-positive cells compared to transfection
with 5 μg DNA (HaCaT: 56% (p = 0.0002); HKC: 51% (p =
0.0032)). Highest efficiency was obtained using 1.1 × 1010
IU Ad-GFP (HaCaT: 84% (p = 0.0138); HKC: 92% (p =
0.0055)), suggesting a concentration dependence in the
transduction efficiency.
In terms of GFP mRNA expression, a concentration of
3.2 μg/g 18S rRNA (HaCaT, p = 0.0009) and 0.7 μg/g 18S
rRNA (HKC, p = 0.01) were detected in cells treated with
adenoviral DNA (Figure 1C). In contrast, keratinocytes
that were transduced with 1.1 × 109 IU of adenoviral vec-
tors, showed a 550-fold (HaCaT, p = 0.0295) or 131-fold
(HKC, p = 0.0070) higher levels of GFP mRNA. A trans-
duction of cells with 1.1 × 1010 IU Ad-GFP led to a 2580-
fold (HaCaT, p = 0.0402) or 398-fold (HKC, p = 0.0018)
higher mRNA concentration in comparison to transfected
cells. In addition, a significantly higher concentration of
GFP mRNA was measured in cells treated with 1.1 ×
1010 IU Ad-GFP in comparison to keratinocytes treated
with 1.1 × 109 IU (HaCaT: p = 0.0296; HKC: p = 0.0071).
Comparative analysis of type-I-interferon expression
Type-I-interferons play a key role in the induction of im-
mune responses to viral infection und are induced im-
mediately after detection of viral components in the host
cell. In addition to its direct antiviral function, these cy-
tokines play an important role in the induction of cyto-
kine expression in surrounding tissue (Kawai & Akira
2006). In summary, showed up with the exception of
IFN-β expression in HaCaT cells, a higher induction of
the expression of type-I-IFN after transduction with
1.1 × 1010 IU of Ad-GFP transfection compared with an
equivalent amount of DNA. Taking account of the trans-
duction and transfection efficiency the data demon-
strates the immunogenic potential of adenoviral DNA in
keratinocytes (Figure 1D).
Evaluation of cytokine expression after adenoviral DNA
internalization
In order to get a deeper insight into cytokine expression
after adenoviral DNA internalization into keratinocytes,an enlarged number of samples was analyzed. For this
purpose the data from tests on different days with cells of
different passages (HaCaT) and different patients (HKC)
were examined at different time-points (type-I-IFN: n = 18
samples; cytokines: n = 6 samples).
The data (Figure 1E) showed a 1.7-fold increased ex-
pression of IFN-α in HaCaT cells (p = 0.0836) and 1.5-
fold in HKC (p = 0.3329). For the expression of IFN-β
mRNA a 26.1-fold, significant increase in HaCaT cells
(p = 0.0029) could be detected. Transfection of primary
keratinocytes, however, resulted in a 11.4-fold increase
(p = 0.0439). The study showed an induction of cyto-
kine gene expression of IL-1α and IL-6 in HaCaT
cells by a factor of 10.3 (IL-1α; p = 0.0972) and 22.1
(IL-6; p = 0.0074) respectively. In contrast, the induction of
IL-1α (2.6-fold; p = 0.0233) and IL-6 (2.1-fold; p = 0.0566)
in HKC was comparatively lower. In addition to the induc-
tion of interferons and interleukins showed the transfection
of keratinocytes also a significant increase of IL-8-encoding
mRNA. In HaCaT cells, a 11.9-fold (p = 0.0038) induction
has been detected whereas HKC possessed a 6.9-fold induc-
tion (p = 0.0312). The expression of TNFα showed mean
values of 4.9-fold induction in HaCaT cells (p = 0.0478) and
1.6-fold increase in HKC (p = 0.5123).Adenovirally induced immune reaction in ex vivo
cultivated human full-thickness skin
Since keratinocytes in a physiologic full skin environ-
ment may react differently from cultured cells, human
full skin explants (n = 6 samples) were intradermally
transduced ex vivo with an adenovirus type 5 vector
(Ad-GFP) (Figure 2A). RT-PCR analysis (Figure 2B)
showed an induction of pro-inflammatory cytokines
peaking 12 h post transduction (IFN-α: 11-fold; p =
0.163); IFN-β: 9-fold, p = 0.168); IL-1α: 7-fold, p = 0.167);
IL-6: 9-fold, p = 0.001); IL-8: 13 -fold, p = 0.076); TNFα:
10-fold, p = 0.133)). A re-increase in expression of IFN-β
(4.5-fold, p = 0.05) and IL-1α (7.8-fold, p = 0.137) could
be observed after 96 h.
Since there is a lack of systemic influences by using
the human ex vivo full skin transduction for an investi-
gation of adenovirus induced systemic immune reac-
tions, the aim of our in vivo study was gaining a deeper
insight into systemic influences towards adenovirus in-
duced inflammatory response in a murine skin transduc-
tion model.Adenovirally induced immune reaction in an in vivo
murine transduction model
In our in vivo study, an application of 1010 IU Ad-GFP
resulted in strong GFP expression with a peak at day 2
and remained detectable for 12 days (Figure 2C). Re-
application of the same dose of Ad-GFP on days 14 and
Figure 2 Immune reaction after cutaneous adenoviral gene delivery. (A) Transduction control of a Bo-Drum®. Representative exposition of a
Bo-Drum® 48 h after transduction of fixed skin sample with 1 × 1010 IU GFP-encoding adenoviral vector (Ad-GFP) (1: transmitted light image; 2:
fluorescent image; 3: overlay). (B) Kinetics of cytokine expression after Bo-Drum® transduction. Time course (3 - 96 h) of cytokine mRNA
expression (x-fold in relation to a vehicle control) after ex vivo transduction of human full skin in relation to a vehicle control (PBS injection). Per
timepoint, n = 6 samples (from two different patients) were transduced with 1 × 1010 IU Ad-GFP (* = p < 0,05; ** = p < 0,005). (C) Adenovirus
induced immune reaction in vivo. GFP-fluorescence detection of immunocompetent, hairless mice (SKH-1h/r) at timepoints of 7–42 days after
intradermal injection (white arrow) of 1010 IU Ad-GFP (n = 3 per group). An additional vector application and reapplication of the same vector
doses was performed on day 14 and 28 (* = p < 0.05, ** = p < 0.005). (D) Type-I-interferon and cytokine expression in vivo. RT-PCR analysis of type-I
-interferon and cytokine expression at timepoints of 1, 6, 24, 48, 72 and 120 h after first application (PBS + AdV) and reapplication (AdV + AdV) of
1010 IU Ad-GFP (* = p < 0.05, # = p < 0.005; AdV + AdV) of 1010 IU Ad-GFP in immunocompetent (SKH-1h/r) (A) and athymic (Foxn-1nu) (B) mice.
Data was presented as mean ± SEM (n = 3 per group/timepoint).
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GFP fluorescence.
In a second experiment, immonucompetent (SKH-1hr)
and athymic (Foxn-1nu) mice were intradermally trans-
duced with 1010 IU Ad-GFP on day 0 followed by a
retransduction with the same vector dose into the same
(AdV + AdV) and two new areas (PBS + AdV) on day14. RT-PCR analysis of skin samples from immunocom-
petent mice showed an induction of IFN-α/β, IL-6, IL-10
and TNF-α 24 to 48 h post transduction (Figure 2D).
RT-PCR analysis of samples from athymic mice
exhibited a faster cytokine induction which was, how-
ever, on a significantly lower level when compared to
immunocompetent mice.
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An induction of innate immunity requires different key
molecules for inflammatory signal transduction, including
MAPK-dependent signaling pathways (Erk2, MAPKK, p38
MAPK), JNK, JAK/STAT-cascades and the transcription
factor NFκB. These factors represent key molecules of the
toll-like receptor signaling pathway, but they can also
interact with members of the RIG-like receptor family or
the DNA-binding receptor DAI (Akira & Hoshino 2003;
Kanehisa 2012; Yoneyama & Fujita 2007). In contrast to
p38 MAPK, JNK and NFκB, an activation of Erk2 has not
been described for the RIG-like receptor and DAI pathway
(Kanehisa 2012).
The following section describes the data of a further
stimulation of keratinocytes using specific inhibitors.
This showed a predominantly significant reduction
of cytokine expression after inhibition of NFκB, JNK,
p38 MAPK and JAK/STAT in HaCaT cells and HKC
(Figure 3). In contrast, inhibition of Erk2 did not show
any significant reduction of cytokine expression. This
data also represents an indication for induction of cyto-
kine expression by RIG-like receptors.
Expression of nucleic acid sensing receptors after
adenoviral DNA delivery
For an examination of the involvement of TLRs, RLRs and
DAI, an analysis of the expression profiles of these recep-
tors and specific adapter molecules using qRT-PCR has
been performed (Figure 4). In HaCaT cells, highest induc-
tion of mRNA expression after transfection was measured
for mda5 (52.08-fold; 12 h post trasfection (p = 0.0267)),
DAI (23.86-fold; 15 h post transfection (p = 0.1349)) and
AIM2 (36.81; 12 h post transfection (p = 0.0421)) whereas
HKC showed a significant increase in the NALP3 mRNA
(3.29-fold, p = 0.0243) only 3 h post transfection.
The data of the strong induction of AIM2 expression
in HaCaT cells suggests a key role of this receptor in
eliciting an anti-adenoviral immune reaction. Further-
more, the expression of NALP3 in HKC was one of pro-
nounced increase in this cell type and may therefore
constitute a key role in the detection of adenoviral DNA.
Additionally, an involvement of IFI16 could not be ex-
cluded. Due to the comparably lower regulation of IFI16
mRNA expression, further analysis focused on the fac-
tors AIM2, NALP3, mda5 and DAI.
Recognition of adenoviral DNA in keratinocytes
For a more detailed statement about the involvement of
specific receptors on the adenoviral-induced immune re-
sponse, the expression of receptors AIM2, NALP3, mda5
and DAI was inhibited in a further experiment using siRNA
over a period of 48 hours. Hence, the cells were transfected
with adenoviral DNA (5 μg/ml medium), and the impact
on interferon expression was determined by qRT-PCR.To check the efficiency of the used siRNA-treated
cells were analyzed for expression of the inhibited
receptors (Figure 5A). All treated samples showed a
reduction of corresponding mRNA expression. The ef-
ficiency of anti-AIM2-siRNA (siAIM2) showed a re-
sidual expression of the mRNA of 71.89% (p = 0.1404)
compared with a control in HaCaT cells and 63.79%
(p = 0.4377) in HKC. The inhibition of NALP3 expres-
sion led to a residual expression of 74.54% (HaCaT,
p = 0.2023) and 64.25% (HKC, p = 0.1987). The highest
efficiency was observed in siMDA5 treated samples
(HaCaT: 43.72%, p = 0.0035; HKC: 27.48%, p = 0.0572).
In siDAI treated samples, a residual mRNA expression
of 81.38% (HaCaT, p = 0.4675) and 67.75% (HKC, p =
0.0923) was detected.
Analysis of type-I-IFN expression of siMDA5 treated
samples offered a significant reduction in expression of
IFN-α and IFN-β in both HaCaTcells and HKC (Figure 5B).
The largest effect on interferon expression was observed in
primary keratinocytes (IFN-α: 38.31%, p = 0.0333), IFN-β:
33.47%, p = 0.0569). In HaCaT cells, a residual expression of
54.11% (IFN-α, p = 0.0180) and 72.99% (IFN-β, p = 0.0262)
was measured.
In case of siAIM2 treated samples, a significantly
greater reduction of IFN-β (HaCaT: 73.11%, p = 0.0355;
HKC: 50.23%, p = 0.2050) compared to IFN-α (HaCaT:
90.57%, p = 0.7026; HKC: 85.30%, p = 0.5735) was shown.
In contrast, the siNALP3 treated samples possessed a
greater reduction of IFN-α (HaCaT: 57.58%, p = 0.0586;
HKC: 73.36%, p = 0.2570) compared to IFN-β (HaCaT:
103.99%, p = 0.3560; HKC: 92.03%, p = 0.7426).
The treatment of keratinocytes with siDAI showed a
matching expression of IFN-α and IFN-β for both cell
types. In HaCaT cells, a residual expression of 71.22%
(IFN-α, p = 0.0690) and 76.15% (IFN-β, p = 0.0546) was
measured. In HKC, an expression of 73.56% (IFN-α, p =
0.1962) and 81.54% (IFN-β, p = 0.4496) were determined.
For an accurate interpretation, the results of type-I-IFN
expression in different samples were normalized to the
corresponding siRNA efficiency (Table 3). The data gener-
ated here will give a closer insight into the role of individ-
ual receptors in the induction of immune response. The
ratio of siRNA efficiency and type-I-IFN expression corre-
lates with the importance of each receptor in the induc-
tion of the immune system, meaning a higher ratio
indicates a greater participation in eliciting an innate im-
mune response.
For this, AIM2 plays an important role in the induction
of IFN-β. In contrast, NALP3, however causes a stronger
induction of IFN-α. DAI plays a major role in the induction
of both IFN-α and IFN-β whereas the RNA-binding
receptor mda5 also plays a role in type-I-IFN induction,
which, however, is lower when compared to AIM2, NALP3
and DAI.
Figure 3 (See legend on next page.)
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Figure 3 Inhibition of signaling cascades. Cytokine expression after transfection of HaCaT cells and HKC with 5 μg/ml of adenoviral DNA with
a follow-up of 15 h (HaCaT) or 6 h (HKC). One hour before transfection, inhibitors of indicated signaling molecules were added to the cell culture
medium (10 mM final concentration). Data is indicated as percentage expression of cytokines in relation to a non-inhibited positive control
(* = p <0.05, ** = p <0.005).
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receptors
In order to investigate the effects of siRNA - mediated gene
silencing on efficacy of transgene expression, HaCaT cells
were incubated with previously mentioned siRNAs over a
period of 48 hours and further transduced with 1 × 108 IU
of Ad5-GFP. After another 48 hours, the reporter fluores-
cence was quantified using a kodak life-imaging station.
Qualitative data analysis of the transduced keratinocytes
(Figure 6A) possessed a stronger transgene fluorescence in
cells treated with siRNA targeting AIM2, NALP3, mda5Figure 4 Induction of innate immune signalling cascades. Induction of
RIG-like receptors (RLR), Interferon-regulatory factors (IRF) and DAI expressio
after transfection of HaCaT cells and HKC with 5 μg/ml of adenoviral DNAand DAI. Quantitative analysis of GFP fluorescence
(Figure 6B) illustrated a 2.24-fold, significantly increased
after inhibition of NALP3 (p = 0.0018). Pre-incubation
with anti-AIM2-siRNA and anti-mda5 siRNA also leads to
a significant increase in reporter fluorescence by a factor
of 1.77 (AIM2, p = 0.0186) and 1.59 (mda5, p = 0.0244). A
1.34-fold amplified signal intensity was found after using
anti-DAI-siRNA (p = 0.0902).
Hence, the data generated in this experiment indi-
cates a primary involvement of the receptors AIM2,
NALP3 and mda5 but also DAI in the induction of theToll-like receptors (TLR), Inflammasome-building components (Inf),
n (x-fold in relation to a vehicle control) 15 h (HaCaT) or 6 h (HKC)
(* = p <0.05, ** = p <0.005).
Figure 5 siRNA-mediated inhibition of gene expression. (A)
Efficiency of siRNA - mediated inhibition of gene expression.
Expression of AIM2, NALP3, mda5 and DAI mRNA in HaCaT cells and
HKC 48 h after siRNA transfection (* = p <0.05, ** = p <0.005). (B)
Effects of siRNA - mediated inhibition of potential receptor gene
expression. Expression of type-I-interferon (x-fold in relation to a
vehicle control) after siRNA-mediated inhibition of potential DNA
receptor mRNA expression. Two days after silencing, cells were
transfected with 5 μg/ml isolated adenoviral DNA for 15 h (HaCaT)
or 6 h (HKC) (* = p <0.05).
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keratinocytes.
Discussion
There are several studies that examine adenovirally in-
duced innate immune reactions in mice, primates and
humans (Raper et al. 2003; Schnell et al. 2001; Zhang
et al. 2001). However, these studies have a propensity to
only address specialized APCs such as DCs or MΦ
(Nociari et al. 2007; Zhu et al. 2007) and RNA virus-
induced immune reactions of APC (Diebold et al. 2004).
In addition, data on the role of keratinocytes in innate
immunity, particularly towards DNA internalization andTable 3 Normalized data of type-I-interferon expression after
potential DNA receptors in HaCaT cells and HKC ([siRNA - Effi
(Expression in % of control)] ± SEM)
AIM2 NALP3
HaCaT HKC HaCaT H
IFN-alpha 0,79± 0,75± 1,29± 0,8
0,15 0,12 0,12 0
IFN-beta 0,98± 1,27± 0,72± 0,7
0,02 0,65 0,01 0DNA virus infection is limited. For optimization of
adenoviral gene delivery into skin it is critical to shed
light on the molecular mechanisms of immunity of epi-
dermal cells. To address these issues, we have investi-
gated the role of keratinocytes in innate immunity in
response to DNA internalization.
This study used the HaCaT cell line as it is simple to
cultivate and experiments were carried out under highly
standardized and reproducible conditions (Boukamp
et al. 1988). The data of constitutive cytokine expression
in HaCaT cells displayed expected differences in com-
parison to HKC. However, these relate primarily to dif-
ferences in expression levels of these factors, while all
measured factors were expressed in both cell types. Con-
sistent with Köllisch et al., HKC and HaCaT cells also
revealed generally comparable data for induction of in-
flammatory factors after transfection of adenoviral DNA
(Köllisch et al. 2005). In comparing both cell types, a dif-
ference in induction intensity and time response of these
inflammatory factors has been detected in a previous
study and could be confirmed by our experiments. How-
ever, HaCaT cells possessed a higher cytokine induction
than HKC whereas HKC exhibited a faster reaction to-
wards adenoviral DNA and might be caused by different
factors like genetic abberations described for HaCaT
cells and due to comparing highly proliferative HaCaT
cell line and predominantly terminal differentiated HKCs
(Steinstraesser et al. 2011).
In order to determine the differences in transfection
and transduction efficacy of keratinocytes, cells were
stimulated isolated adenoviral DNA or an equal dose of
adenoviral vectors. The transduction efficacy of adeno-
viral vectors was 83% for HaCaT and 92% for HKC re-
spectively, while transfection of keratinocytes with an
equivalent dose of adenoviral DNA possessed a signifi-
cant lower efficacy (HaCaT: 15%; HKC: 9%). In regard to
transfection and transduction efficacy, transfection re-
vealed a type-I-IFN expression on a comparative level as
measured after transduction of keratinocytes and points
out an important role of adenoviral DNA in the induc-
tion of innate immune response in keratinocytes.
As discussed above, recognition of cytoplasmatic local-
ized viral DNA triggers the antiviral innate immunesiRNA - mediated inhibition of gene expression of
ciency (Expression in % of control)/type-I-IFN expression
mda5 DAI
KC HaCaT HKC HaCaT HKC
8± 0,81± 0,71± 1,14± 0,92±
,15 0,07 0,03 0,04 0,11
0± 0,60± 0,82± 1,07± 0,83±
,07 0,03 0,3 0,09 0,03
Figure 6 Transgene expression after siRNA-mediated gene
expression of AIM2, NALP3, mda5 and DAI. Quantitative (A) and
qualitative (B) representation of the GFP expression in HaCaT cells
48 h after siRNA - mediated inhibition of AIM2, NALP3, mda5 and
DAI and subsequent transduction with 1 × 108 IU Ad5-GFP or PBS
(control) (* = p < 0.05; ** = p < 0.005).
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immunity independent of the species and sequence of
the internalized DNA; the induction of type-I-interferon
and cytokine synthesis during introduction of nucleic
acids into the cytoplasm of APCs has been shown by dif-
ferent groups (Ishii et al. 2001; Yasuda et al. 2005). Data
regarding immunogenicity of cytoplasmatic localized
DNA in epidermal cells is limited. For this purpose, this
study demonstrates a high induction of IFN-α/β, pro-
inflammatory cytokines and chemokines by adenoviral
DNA internalization in vitro, ex vivo and in vivo
(Steinstraesser et al. 2011).
Obtained in vivo data suggests immunization against
adenovirus, which led to decreased intensity and dur-
ation of transgene expression after reapplication of the
identical vector dose into the same or non-transduced
areas in immuncompetent mice. Therefore, therapeutic
reapplication of the vector into keratinocytes to stabilize
transgene expression may be unefficient (Nociari et al.
2007; Zhu et al. 2007). Moreover, athymic mice showed
a diminished type-I-IFN and cytokine expression (Figure 2D)
and a stable GFP level starting from day 5 (Steinstraesser
et al. 2011), suggesting the possibility to optimize
adenoviral gene delivery by modulating the inflamma-
tory responses of the skin. An early decrease in GFP
level detected in immunocompetent and athymic mice
from day 2 to 5 denotes a T-cell independent mechan-
ism for a reduction of GFP level (Steinstraesser et al.
2011) and was dedicated to an induction of innate im-
munity (Muruve 2004). Moreover, data from athymic
mice and in vitro stimulation of keratinocytes suggests
an important role of keratinocytes in eliciting an innate
immune reaction after adenoviral challenge.
In previous years, many studies regarding the molecu-
lar mechanisms in DNA recognition were evaluated forthe stimulation of different cell types with various spe-
cies of DNA. For example, several groups have shown a
major role of TLRs, the DNA - binding protein DAI as
well as special forms of the inflammasome (AIM2,
NALP3, IFI16) in macrophages, dendritic cells and fibro-
blasts (Goubau et al. 2010; Nociari et al. 2007; Takaoka
et al. 2007; Unterholzner et al. 2010; Zhu et al. 2007).
However, our current understanding of the signal
transduction after recognition of adenoviral DNA in
keratinocytes is still rather limited. For the establishment
of cutaneous adenoviral gene delivery, information about
immune reactions towards adenoviral DNA is of high
importance.
The data from this study depicted a special role of the
JAK/STAT signaling pathway in induction of type-I-IFN.
Since JAK/STAT plays a major role in signal transduc-
tion of type-I-IFN- and cytokinereceptors, the involve-
ment of the JAK/STAT signaling pathway in antiviral
immunity was not unexpected.
Additionally, NFκB, JNK and p38 MAPK but not Erk2
were also characterized as important factors in adenovirally
induced signal transduction. The proteins NFκB, p38
MAPK and JNK play an important role not only in the
TLR mediated signal transduction but also in RLR-
dependent (RIG-I and mda5) signaling (Kanehisa 2012).
Since Erk2/MAPKK are not addressed by the TLR pathway,
the lack of participation of Erk2/MAPKK in activation of
type-I-IFN expression suggests an RLR-dependent pathway
for adenoviral DNA recognition (Kanehisa 2012).
In analyzing potentially in adenovirus recognition in-
volved receptor systems, a significant induction of mda5
was observed. An activation of RLRs is associated with
an involvement of IRFs, NFκB, p38 MAPK and JNK,
confirming the previous results of the inhibitor study.
Since a signal transduction occurs via RLRs, which do
not address Erk2/MAPKK, thus would explain the re-
sults of the type-I-IFN expression after inhibition of
Erk2/MAPKK.
Additionally, there was also an induction of mRNA ex-
pression of NALP3- and AIM2 inflammasomes. Hence,
a significant induction of inflammasome-activated
caspase-1 and IL-1β, which is processed by caspase-1,
was shown for both cell types. This fact suggests an in-
volvement of inflammasomes in the adenovirally induced
immune response.
In addition to the previously detected increased ex-
pressions of AIM2, NALP3 and mda5, the analysis of the
DAI expression possessed a significant increase in
HaCaT cells. This also indicates an involvement of this
protein out of the adenovirally induced immune re-
sponse and may also explain the NFκB dependence seen
in the inhibitor study.
Since an analysis of keratinocytes derived from expres-
sion profiles only permits a tendency of the molecular
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concerning the participation of the above mentioned re-
ceptors, however, can only be provided by targeted in-
hibition of these factors. Therefore, potential receptor
molecules that were identified in the preliminary screen-
ing, were silenced using siRNA in order to get a closer
information about their involvement in recognition of
adenoviral DNA.
Considering the data of siRNA efficacy, the greatest effect
of type-I-IFN expression was measured in keratinocytes
with reduced expression of AIM2, NALP3 and DAI. On
this occasion NALP3- and AIM2-inhibited samples pos-
sessed an opposite trend in induction of interferons:
Silencing of NALP3 had a greater effect on IFN-α ex-
pression and silencing of AIM2 a greater effect on IFN-
β expression. In case of transfection of keratinocytes
with adenoviral DNA, mda5 plays also role in induction
of innate immune reaction.
An additionally performed transduction of keratinocytes
treated with siRNA blocking AIM2, NALP3, DAI and
mda5 gene expression possessed an increase in GFP pro-
tein level. Interestingly, the experiments carried out a par-
ticipation of RLRs, particularly mda5 in adenovirus
recognition. The activation of p38 MAPK, JNK, and
NFκB, but not Erk2, which has been reported in this study,
clearly supports this thesis (Kanehisa 2012).
Since mda5 has been described as a RNA recognizing re-
ceptor, it should principally not be involved in adenovirus
recognition (Kawai & Akira 2008). In the literature, how-
ever, another publication concerning a mda5-dependent
induction of an immune response after infection of mono-
cytes with a DNA virus (vaccinia virus modified Ankara,
MVA) was found (Delaloye et al. 2009). The exact mechan-
ism of mda5-induced immune response could not be clari-
fied in that study. One possible explanation for this might
be a detection of transcripts of AT-rich DNA sequences in
the cytoplasm (Bauernfeind et al. 2010). These are encoded
by the late regions of the adenoviral genome, are respon-
sible for inhibiting the activity of protein kinase R after in-
fection of a cell responsible and are produced in quantities
of 108 copies per cell (Acheson 2011). This also underlines
the thesis of RLR-induced induction of the immune re-
sponse in keratinocytes.
Although the science of cutaneous adenoviral gene de-
livery is complex and riddled into many isolated experi-
ments. Since knowledge about signal transduction of
innate immune reaction after adenoviral gene delivery
into skin is very limited, data about an involvement of
AIM2, NALP3, DAI and mda5 in detection of adenoviral
DNA adds new features in our understanding of current
scopes and future opportunities of cutaneous gene ther-
apy using adenoviral vector systems. Further studies are
needed to improve our knowledge in molecular mecha-
nisms of signal transduction in adenovirus inducedimmune reactions of the skin. Their contribution re-
mains vital to continue to search for clues, yet their
exact role in the overall context in molecular mecha-
nisms in innate immunity of the skin is still to be
understood.
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